Electrochemical detection of anti-breast-cancer agents in Human Serum by Cytochrome P450-coated Carbon nanotubes

Sensors (Switzerland)

Volumn 12, Issue 5, 2012, Pages 6520-6537

  Baj Rossi, Camilla ^a   de Micheli, Giovanni ^a   Carrara, Sandro ^a  

^a EPFL   (Switzerland)

Author keywords

Breast cancer; Carbon nanotubes; Cytochrome P450; Electrochemical drugs detection; Human serum; Personalized therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CARBON NANOTUBE; CYTOCHROME P450;

ARTICLE; BLOOD; BREAST TUMOR; CHEMISTRY; ELECTROCHEMICAL ANALYSIS; FEMALE; GENETIC PROCEDURES; HUMAN; METHODOLOGY; SCANNING ELECTRON MICROSCOPY;

ANTINEOPLASTIC AGENTS; BIOSENSING TECHNIQUES; BREAST NEOPLASMS; CYTOCHROME P-450 ENZYME SYSTEM; ELECTROCHEMICAL TECHNIQUES; FEMALE; HUMANS; MICROSCOPY, ELECTRON, SCANNING; NANOTUBES, CARBON;

EID: 84861533810     PISSN: 14248220     EISSN: None     Source Type: Journal    
DOI: 10.3390/s120506520     Document Type: Article

References (65)

1. Bistolas, N.; Wollenberger, U.; Jung, C.; Scheller, F.W. Cytochrome p450 biosensors-a review. Biosens. Bioelectron. 2005, 20, 2408-2423.
2. Johnson, D.L.; Lewis, B.C.; Elliot, D.J.; Miners, J.O.; Martin, L.L. Electrochemical characterisation of the human cytochrome p450 cyp2c9. Biochem. Pharmacol. 2005, 69, 1533-1541.
3. Guengerich, F.P. Cytochrome p450 and chemical toxicology. Chem. Res. Toxicol. 2008, 21, 70-83.
4. Shumyantseva, V.V.; Bulko, T.V.; Usanov, S.A.; Schmid, R.D.; Nicolini, C.; Archakov, A.I. Construction and characterization of bioelectrocatalytic sensors based on cytochromes p450. J. Inorg. Biochem. 2001, 87, 185-190.
5. Carrara, S.; Shumyantseva, V.; Archakov, A.; Samorì, B. Screen-printed electrodes based on carbon nanotubes and cytochrome p450scc for highly sensitive cholesterol biosensors. Biosens. Bioelectron. 2008, 24, 148-150.
6. Joseph, S.; Rusling, J.F.; Lvov, Y.M.; Friedberg, T.; Fuhr, U. An amperometric biosensor with human cyp3a4 as a novel drug screening tool. Biochem. Pharmacol. 2003, 65, 1817-1826.
7. Liu, S.; Peng, L.; Yang, X.; Wu, Y.; He, L. Electrochemistry of cytochrome p450 enzyme on nanoparticle-containing membrane-coated electrode and its applications for drug sensing. Anal. Biochem. 2008, 375, 209-216.
8. Iwuoha, E.I.; Wilson, A.; Howel, M.; Mathebe, N.G.R.; Montane Jaime, K.; Narinesingh, D.; Guiseppi Elie, A. Cytochrome p4502d6 (cyp2d6) bioelectrode for fluoxetine. Anal. Lett. 2005, 37, 929-941.
9. Atkins, W.M. Non-michaelis-menten kinetics in cytochrome p450-catalyzed reactions. Annu. Rev. Pharmacol. Toxicol. 2005, 45, 291-310.
10. Houston, J.B.; Galetin, A. Modelling atypical cyp3a4 kinetics: Principles and pragmatism. Arch. Biochem. Biophys. 2005, 433, 351-360.
11. He, P.; Hu, N.; Rusling, J.F. Driving forces for layer-by-layer self-assembly of films of sio2 nanoparticles and heme proteins. Langmuir 2003, 20, 722-729.
12. Shumyantseva, V.V.; Carrara, S.; Bavastrello, V.; Jason Riley, D.; Bulko, T.V.; Skryabin, K.G.; Archakov, A.I.; Nicolini, C. Direct electron transfer between cytochrome p450scc and gold nanoparticles on screen-printed rhodium-graphite electrodes. Biosens. Bioelectron. 2005, 21, 217-222.
13. Wu, Y.; Hu, S. Biosensors based on direct electron transfer in redox proteins. Microchim. Acta 2007, 159, 1-17.
14. Luo, X.; Morrin, A.; Killard, A.J.; Smyth, M.R. Application of nanoparticles in electrochemical sensors and biosensors. Electroanalysis 2006, 18, 319-326.
15. Wang, J. Nanomaterial-based electrochemical biosensors. Analyst 2005, 130, 421-426.
16. Zhang, X.; Guo, Q.; Cui, D. Recent advances in nanotechnology applied to biosensors. Sensors 2009, 9, 1033-1053.
17. Wang, J. Carbon-nanotube based electrochemical biosensors: A review. Electroanalysis 2005, 17, 7-14.
18. Zhao, Q.; Gan, Z.; Zhuang, Q. Electrochemical sensors based on carbon nanotubes. Electroanalysis 2002, 14, 1609-1613.
19. Lin, Y.; Lu, F.; Tu, Y.; Ren, Z. Glucose biosensors based on carbon nanotube nanoelectrode ensembles. Nano Lett. 2003, 4, 191-195.
20. Gooding, J.J. Nanostructuring electrodes with carbon nanotubes: A review on electrochemistry and applications for sensing. Electrochim. Acta 2005, 50, 3049-3060.
21. Hortobagyi, G.N. Treatment of breast cancer. N. Engl. J. Med. 1998, 339, 974-984.
22. Smith, I.C.; Heys, S.D.; Hutcheon, A.W.; Miller, I.D.; Payne, S.; Gilbert, F.J.; Ah-See, A.K.; Eremin, O.; Walker, L.G.; Sarkar, T.K.; et al. Neoadjuvant chemotherapy in breast cancer: Significantly enhanced response with docetaxel. J. Clin. Oncol. 2002, 20, 1456-1466.
23. Roy, P.; Yu, L.J.; Crespi, C.L.; Waxman, D.J. Development of a substrate-activity based approach to identify the major human liver p-450 catalysts of cyclophosphamide and ifosfamide activation based on cdna-expressed activities and liver microsomal p-450 profiles. Drug Metab. Dispos. 1999, 27, 655-666.
24. Huang, Z.; Roy, P.; Waxman, D.J. Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide. Biochem. Pharmacol. 2000, 59, 961-972.
25. Komatsu, T.; Yamazaki, H.; Shimada, N.; Nakajima, M.; Yokoi, T. Roles of cytochromes p450 1a2, 2a6, and 2c8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes. Drug Metab. Dispos. 2000, 28, 1457-1463.
26. Komatsu, T.; Yamazaki, H.; Shimada, N.; Nagayama, S.; Kawaguchi, Y.; Nakajima, M.; Yokoi, T. Involvement of microsomal cytochrome p450 and cytosolic thymidine phosphorylase in 5-fluorouracil formation from tegafur in human liver. Clin. Cancer. Res. 2001, 7, 675-681.
27. Zhuo, X.; Zheng, N.; Felix, C.A.; Blair, I.A. Kinetics and regulation of cytochrome p450-mediated etoposide metabolism. Drug Metab. Dispos. 2004, 32, 993-1000.
28. Chen, J.H.; Li, W.Z.; Wang, D.Z.; Yang, S.X.; Wen, J.G.; Ren, Z.F. Electrochemical characterization of carbon nanotubes as electrode in electrochemical double-layer capacitors. Carbon 2002, 40, 1193-1197.
29. Carrara, S.; Cavallini, A.; Garg, A.; de Micheli, G. Dynamical Spot Queries to Improve Specificity in p450s Based Multi-Drugs Monitoring. In Proceeding of ICME International Conference on Complex Medical Engineering, Tempe, AZ, USA, 9-11 April 2009; pp. 1-6.
30. Lavagnini, I.; Antiochia, R.; Magno, F. A calibration-base method for the evaluation of the detection limit of an electrochemical biosensor. Electroanalysis 2007, 19, 1227-1230.
31. Mocak, J. A statistical overview of standard (iupac and acs) and new procedures for determining the limits of detection and quantification: Application to voltammetric and stripping techniques. Pure Appl. Chem. 1997, 69, 297.
32. Shumyantseva, V.V.; Ivanov, Y.D.; Bistolas, N.; Scheller, F.W.; Archakov, A.I.; Wollenberger, U. Direct electron transfer of cytochrome p450 2b4 at electrodes modified with nonionic detergent and colloidal clay nanoparticles. Anal. Chem. 2004, 76, 6046-6052.
33. Lyons, M.E.G.; Keeley, G.P. Carbon nanotube based modified electrode biosensors. Part 1. Electrochemical studies of the flavin group redox kinetics at swcnt/glucose oxidase composite modified electrodes. Int. J. Electrochem. Sci. 2008, 3, 819-853.
34. Novotny, J.; Bruccoleri, R.E.; Saul, F.A. on the attribution of binding energy in antigen-antibody complexes mcpc 603, d1.3, and hyhel-5. Biochemistry 1989, 28, 4735-4749.
35. Davis, J.J.; Djuricic, D.; Lo, K.K.; Wallace, E.N.; Wong, L.L.; Hill, H.A. A scanning tunnelling study of immobilised cytochrome p450cam. Faraday Discuss. 2000, 116, 15-22; discussion 67-75.
36. Ravichandran, K.G.; Boddupalli, S.S.; Hasermann, C.A.; Peterson, J.A.; Deisenhofer, J. Crystal structure of hemoprotein domain of p450bm-3, a prototype for microsomal p450's. Science 1993, 261, 731-736.
37. Rivas, L.; Murgida, D.H.; Hildebrandt, P. Conformational and redox equilibria and dynamics of cytochrome c immobilized on electrodes via hydrophobic interactions. J. Phys. Chem. B 2002, 106, 4823-4830.
38. Williams, P.A.; Cosme, J.; Sridhar, V.; Johnson, E.F.; McRee, D.E. Microsomal cytochrome p450 2c5: Comparison to microbial p450s and unique features. J. Inorg. Biochem. 2000, 81, 183-190.
39. Murgida, D.H.; Hildebrandt, P. Electron-transfer processes of cytochrome c at interfaces. New insights by surface-enhanced resonance raman spectroscopy. Acc. Chem. Res. 2004, 37, 854-861.
40. de Montellano, P.R.O. Cytochrome p450; Plenum Publishers: New York, NY, USA, 2005.
41. Macdonald, I.D.G.; Smith, W.E. Orientation of cytochrome c adsorbed on a citrate-reduced silver colloid surface. Langmuir 1996, 12, 706-713.
42. Bradley, K.; Briman, M.; Star, A.; Grüner, G. Charge transfer from adsorbed proteins. Nano Lett. 2004, 4, 253-256.
43. Boero, C.; Carrara, S.; Del Vecchio, G.; Calza, L.; de Micheli, G. Highly sensitive carbon nanotube-based sensing for lactate and glucose monitoring in cell culture. IEEE Trans. Nanobiosci. 2011, 10, 59-67.
44. Luque, G.L.; Ferreyra, N.F.; Rivas, G.A. Glucose biosensor based on the use of a carbon nanotube paste electrode modified with metallic particles. Microchim. Acta 2006, 152, 277-283.
45. Rubianes, M.D.; Rivas, G.A. Carbon nanotubes paste electrode. Electrochem. Commun. 2003, 5, 689-694.
46. Wang, J.; Li, M.; Shi, Z.; Li, N.; Gu, Z. Direct electrochemistry of cytochrome c at a glassy carbon electrode modified with single-wall carbon nanotubes. Anal. Chem. 2002, 74, 1993-1997.
47. Banks, C.E.; Davies, T.J.; Wildgoose, G.G.; Compton, R.G. Electrocatalysis at graphite and carbon nanotube modified electrodes: Edge-plane sites and tube ends are the reactive sites. Chem. Commun. 2005, 829-841.
48. Holthuis, J.J.M.; van Oort, W.J.; Römkens, F.M.G.M.; Renema, J.; Zuman, P. Electrochemistry of podophyllotoxin derivatives: Part I. Oxidation mechanism of etoposide (VP 16-213). J. Electroanal. Chem. Interfacial Electrochem. 1985, 184, 317-329.
49. Antonini, M.; Ghisellini, P.; Pastorino, L.; Paternolli, C.; Nicolini, C. Preliminary electrochemical characterisation of cytochrome p4501a2-clozapine interaction. IEE Proc. Nanobiotechnol. 2003, 150, 31-34.
50. Shumyantseva, V.V.; Ivanov, Y.D.; Bistolas, N.; Scheller, F.W.; Archakov, A.I.; Wollenberger, U. Direct electron transfer of cytochrome p450 2b4 at electrodes modified with nonionic detergent and colloidal clay nanoparticles. Anal. Chem. 2004, 76, 6046-6052.
51. Peng, L.; Yang, X.; Zhang, Q.; Liu, S. Electrochemistry of cytochrome p450 2b6 on electrodes modified with zirconium dioxide nanoparticles and platin components. Electroanalysis 2008, 20, 803-807.
52. Iwuoha, E.; Ngece, R.; Klink, M.; Baker, P. Amperometric responses of cyp2d6 drug metabolism nanobiosensor for sertraline: A selective serotonin reuptake inhibitor. IET Nanobiotechnol. 2007, 1, 62-67.
53. Fantuzzi, A.; Fairhead, M.; Gilardi, G. Direct electrochemistry of immobilized human cytochrome p450 2e1. J. Am. Chem. Soc. 2004, 126, 5040-5041.
54. Ignaszak, A.; Hendricks, N.; Waryo, T.; Songa, E.; Jahed, N.; Ngece, R.; Al-Ahmed, A.; Kgarebe, B.; Baker, P.; Iwuoha, E.I. Novel therapeutic biosensor for indinavir-A protease inhibitor antiretroviral drug. J. Pharm. Biomed. Anal. 2009, 49, 498-501.
55. Juma, F.D. Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration. Br. J. Clin. Pharmacol. 1979, 8, 209-217.
56. Singer, J.M. The pharmacokinetics and metabolism of ifosfamide during bolus and infusional administration: A randomized cross-over study. Br. J. Cancer 1998, 77, 978-984.
57. Liu, K. Determination of tegafur, 5-fluorouracil, gimeracil and oxonic acid in human plasma using liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 2010, 52, 550-556.
58. Hande, K.R. Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients. Cancer Res. 1984, 44, 379-382.
59. Carrara, S.; Cavallini, A.; Erokhin, V.; de Micheli, G. Multi-panel drugs detection in human serum for personalized therapy. Biosens. Bioelectron. 2011, 26, 3914-3919.
60. Noort, D.; Hulst, A.; Jansen, R. Covalent binding of nitrogen mustards to the cysteine-34 residue in human serum albumin. Arch. Toxicol. 2002, 76, 83-88.
61. Sulkowska, A. Interaction of drugs with bovine and human serum albumin. J. Mol. Struct. 2002, 614, 227-232.
62. Yoko, S.; Yoshiji, T.; Yasufumi, S.; Manabu, H.; Teruyoshi, M.; Yukihiko, U. Prediction of ftorafur disposition in rats and man by a physiologically based pharmacokinetic model. Int. J. Pharm. 1985, 25, 347-358.
63. Stewart, C.F.; Fleming, R.A.; Arbuck, S.G.; Evans, W.E. Prospective evaluation of a model for predicting etoposide plasma protein binding in cancer patients. Cancer Res. 1990, 50, 6854-6856.
64. Kawashiro, T.; Yamashita, K.; Zhao, X.-J.; Koyama, E.; Tani, M.; Chiba, K.; Ishizaki, T. A study on the metabolism of etoposide and possible interactions with antitumor or supporting agents by human liver microsomes. J. Pharmacol. Exp. Ther. 1998, 286, 1294-1300.
65. Chang, T.K.H.; Yu, L.; Maurel, P.; Waxman, D.J. Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: Response to cytochrome p-450 inducers and autoinduction by oxazaphosphorines. Cancer Res. 1997, 57, 1946-1954.